Myriad Genetics (MYGN) Other Working Capital Changes (2016 - 2025)
Myriad Genetics (MYGN) has disclosed Other Working Capital Changes for 17 consecutive years, with $300000.0 as the latest value for Q4 2025.
- Quarterly Other Working Capital Changes rose 133.33% to $300000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2025, down 8.11% year-over-year, with the annual reading at $3.4 million for FY2025, 8.11% down from the prior year.
- Other Working Capital Changes for Q4 2025 was $300000.0 at Myriad Genetics, down from $2.8 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $6.6 million in Q4 2022, with the low at -$24.8 million in Q3 2021.
- Average Other Working Capital Changes over 5 years is -$900000.0, with a median of $200000.0 recorded in 2023.
- The sharpest move saw Other Working Capital Changes crashed 4033.33% in 2021, then soared 3400.0% in 2024.
- Over 5 years, Other Working Capital Changes stood at -$6.2 million in 2021, then skyrocketed by 206.45% to $6.6 million in 2022, then tumbled by 130.3% to -$2.0 million in 2023, then surged by 55.0% to -$900000.0 in 2024, then skyrocketed by 133.33% to $300000.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods came in at $300000.0, $2.8 million, and -$200000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.